3-Chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)pyridin-2-amine

Catalog No. :
ACSCWE421
CAS No. :
1219967-65-3
Molecular Formula :
C14H18ClF3N2
Molecular Weight :
306.76

IUPAC Name:3-chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)pyridin-2-amine

3-Chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$155.00Login to see priceInquiryInquiry
5g95%$466.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)pyridin-2-amine
IUPAC Name3-chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)pyridin-2-amine
MDL No.MFCD13561846
Molecular FormulaC14H18ClF3N2
Molecular Weight306.76
SMILESFC(C1=CN=C(N(C2CCCCC2)CC)C(Cl)=C1)(F)F
InChI KeyLAHPVDGRVRCUGQ-UHFFFAOYSA-N
Synonym3-Chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)-2-pyridinamine;3-CHLORO-N-CYCLOHEXYL-N-ETHYL-5-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE;2-Pyridinamine, 3-chloro-N-cyclohexyl-N-ethyl-5-(trifluoromethyl)-
CAS No.1219967-65-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSCWE421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSCWE421 route product structure diagram
    ACSCWE4211219967-65-3
Inquiry

2. ACSCWE421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSCWE421 route product structure diagram
    ACSCWE4211219967-65-3
Inquiry

Comments (0)